Skip to main content
Yanjiu Conference logo

Abstract Submission – ICGCFT 2027, Istanbul

International Conference on Genomics, CRISPR & Future Therapeutics — ICGCFT 2027

Dates

21–22 January 2027

Venue

Istanbul, Turkey

Field

Genomics, CRISPR & Future Therapeutics

Submit Your Abstract

ICGCFT 2027 welcomes original, unpublished research in Genomics, CRISPR & Future Therapeutics and related areas. Send an abstract or a full paper: every submission is checked for plagiarism and peer reviewed before acceptance.

  1. Step 1: Prepare your abstract

    Write 150–250 words in English stating the purpose, method and main findings of your research. Use the sample paper if you send a full paper, and run your own plagiarism check first.

  2. Step 2: Submit online

    Use the online submission form and choose ICGCFT 2027. You can also email your file to [email protected].

  3. Step 3: Wait for the decision

    You are told by email within about one week whether your abstract is accepted. All notifications go to your registered email and mobile number, so please check both.

  4. Step 4: Send the full paper and register

    Authors of accepted abstracts send the full paper for review and register before the last date of registration, so that the paper is included in the programme and the proceedings.

Submission Requirements

Submission requirements of ICGCFT 2027
ItemRequirement
OriginalityNot published, accepted or under review anywhere else.
AuthorsThe correct affiliation of every author and co-author is shown in the paper; inform your head of department, principal or guide about the submission.
PresenterAt least one author or co-author registers and presents the paper, in person or online.
Accepted typesResearch papers, review papers, case studies, abstracts and posters.
FormatFull papers follow the sample paper (double column), sent as DOC or DOCX for editing.
Without a paperAttend as a listener: no paper is needed.

Read the full submission guidelines

See You in Istanbul This January

Present your research, meet peers from over 50 countries and help shape the future of Genomics, CRISPR & Future Therapeutics.